DK0910405T3 - Vaccine, som indeholder caprint arthritis-encephalitis-virus, og anvendelse til immunbeskyttelse imod HIV-1-infektion - Google Patents
Vaccine, som indeholder caprint arthritis-encephalitis-virus, og anvendelse til immunbeskyttelse imod HIV-1-infektionInfo
- Publication number
- DK0910405T3 DK0910405T3 DK97916761T DK97916761T DK0910405T3 DK 0910405 T3 DK0910405 T3 DK 0910405T3 DK 97916761 T DK97916761 T DK 97916761T DK 97916761 T DK97916761 T DK 97916761T DK 0910405 T3 DK0910405 T3 DK 0910405T3
- Authority
- DK
- Denmark
- Prior art keywords
- infection
- caev
- encephalitis virus
- protection against
- caprine arthritis
- Prior art date
Links
- 241000713756 Caprine arthritis encephalitis virus Species 0.000 title abstract 7
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 208000031886 HIV Infections Diseases 0.000 title 1
- 230000002163 immunogen Effects 0.000 abstract 3
- 208000015181 infectious disease Diseases 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 230000028993 immune response Effects 0.000 abstract 2
- 230000004936 stimulating effect Effects 0.000 abstract 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 210000004698 lymphocyte Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/616,855 US5770357A (en) | 1996-03-15 | 1996-03-15 | Method of diagnosing caprine arthritis-encephalitis virus infection |
| US08/616,854 US6033672A (en) | 1996-03-15 | 1996-03-15 | Method of stimulating an immune response to caprine arthritis-encephalitis virus (CAEV) in humans through the administration of CAEV immunogens |
| PCT/US1997/004020 WO1997033615A2 (en) | 1996-03-15 | 1997-03-14 | Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0910405T3 true DK0910405T3 (da) | 2002-02-18 |
Family
ID=27087888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97916761T DK0910405T3 (da) | 1996-03-15 | 1997-03-14 | Vaccine, som indeholder caprint arthritis-encephalitis-virus, og anvendelse til immunbeskyttelse imod HIV-1-infektion |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0910405B1 (zh) |
| JP (1) | JP2002503205A (zh) |
| CN (1) | CN1236818C (zh) |
| AT (1) | ATE207364T1 (zh) |
| AU (1) | AU732865B2 (zh) |
| DE (1) | DE69707680T2 (zh) |
| DK (1) | DK0910405T3 (zh) |
| ES (1) | ES2165042T3 (zh) |
| HK (1) | HK1021133A1 (zh) |
| PT (1) | PT910405E (zh) |
| RU (1) | RU2194529C2 (zh) |
| WO (1) | WO1997033615A2 (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6602505B2 (en) * | 1998-04-30 | 2003-08-05 | University Of Southern California | Viral chimeras comprised of CAEV and HIV-1 genetic elements |
| WO2004024129A1 (en) * | 2002-09-10 | 2004-03-25 | Samir Chachoua | Induced remission therapy |
| CN107488219A (zh) * | 2017-08-07 | 2017-12-19 | 新疆畜牧科学院 | 一种山羊关节炎‑脑炎病毒血清抗体诊断标记蛋白gp135及其制备方法 |
| CN107632153B (zh) * | 2017-08-07 | 2019-05-24 | 新疆畜牧科学院 | 一种小反刍动物慢病毒间接elisa检测试剂盒 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2721618B1 (fr) * | 1994-06-28 | 1996-09-13 | Centre Nat Rech Scient | Fragments d'acide nucléique et fragments peptidiques correspondants issus du génome du virus de l'arthrite et de l'encéphalite caprine (VAEC) et leurs applications. |
| FR2732346B1 (fr) * | 1995-03-27 | 1997-05-30 | Centre Nat Rech Scient | Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications |
-
1997
- 1997-03-14 EP EP97916761A patent/EP0910405B1/en not_active Expired - Lifetime
- 1997-03-14 RU RU98118995/14A patent/RU2194529C2/ru active
- 1997-03-14 DE DE69707680T patent/DE69707680T2/de not_active Expired - Lifetime
- 1997-03-14 AT AT97916761T patent/ATE207364T1/de not_active IP Right Cessation
- 1997-03-14 JP JP53285797A patent/JP2002503205A/ja not_active Withdrawn
- 1997-03-14 DK DK97916761T patent/DK0910405T3/da active
- 1997-03-14 WO PCT/US1997/004020 patent/WO1997033615A2/en active IP Right Grant
- 1997-03-14 ES ES97916761T patent/ES2165042T3/es not_active Expired - Lifetime
- 1997-03-14 AU AU25297/97A patent/AU732865B2/en not_active Ceased
- 1997-03-14 PT PT97916761T patent/PT910405E/pt unknown
- 1997-03-14 CN CNB971938717A patent/CN1236818C/zh not_active Expired - Fee Related
-
1999
- 1999-12-08 HK HK99105721A patent/HK1021133A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0910405B1 (en) | 2001-10-24 |
| JP2002503205A (ja) | 2002-01-29 |
| WO1997033615A2 (en) | 1997-09-18 |
| CN1236818C (zh) | 2006-01-18 |
| RU2194529C2 (ru) | 2002-12-20 |
| ATE207364T1 (de) | 2001-11-15 |
| ES2165042T3 (es) | 2002-03-01 |
| PT910405E (pt) | 2002-03-28 |
| DE69707680T2 (de) | 2002-07-11 |
| AU2529797A (en) | 1997-10-01 |
| HK1021133A1 (en) | 2000-06-02 |
| WO1997033615A3 (en) | 1998-03-05 |
| DE69707680D1 (de) | 2001-11-29 |
| AU732865B2 (en) | 2001-05-03 |
| EP0910405A2 (en) | 1999-04-28 |
| CN1219881A (zh) | 1999-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO802446L (no) | Optisk aktive 1-,4-dihydropyridin, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel | |
| ES2139017T3 (es) | Compuestos que inhiben la replicacion del vih. | |
| ATE476983T1 (de) | Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen der atemwege | |
| PT1159298E (pt) | Péptidos de hiv, antigénios, composições de vacinas, kit de imunoensaio e um método de detecção de anticorpos induzidos por hiv | |
| MX9308025A (es) | Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene. | |
| DK0910405T3 (da) | Vaccine, som indeholder caprint arthritis-encephalitis-virus, og anvendelse til immunbeskyttelse imod HIV-1-infektion | |
| DK56389D0 (da) | Forhindring og behandling af retroviralt frembragte sygdomme | |
| DK0859613T3 (da) | Anvendelse af flupirtin til forebyggelse og behandling af sygdomme, som er forbundet med beskadigelse af det hæmopoietiske cellesystem | |
| RU94045248A (ru) | Способ ингибирования активности вируса иммунодефицита человека (hiv) in vivo | |
| NO905301L (no) | Malaria - vaksine. | |
| IL139360A0 (en) | Viral chimeras comprised of caev and hiv-1 genetic elements | |
| KR900700626A (ko) | 사람 면역결핍 바이러스-1 gp160으로부터 유도된 보호 펩티드 | |
| CA2249736A1 (en) | Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection | |
| WO2001008702A3 (en) | Immunotherapy in hiv infected persons using vaccines after multi-drug treatment | |
| HUP0100937A2 (hu) | Többszörösen elágazó peptidkonstrukciókat tartalmazó liposzómák és alkalmazásuk humán immundeficiencia vírus ellen | |
| ES2057008T3 (es) | Medicamento. | |
| ES2104695T3 (es) | Induccion de proteccion contra una infeccion virica. | |
| WO1997026880A3 (en) | Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients | |
| ES2055610T3 (es) | Vacuna contra hrsv. | |
| WO1993014760A3 (en) | Methods | |
| DK0545991T3 (da) | Peptider, der blokerer infektioner med human immundefektvirus, og fremgangsmåder til anvendelse deraf | |
| EA199700353A1 (ru) | Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции | |
| DK0542895T3 (da) | Krydsreaktiv influenza A immunisering | |
| DK192990D0 (da) | Laegemiddel til behandling eller forhindring, ved passiv immunisering, af hiv infektion og fremgangsmaader til fremstilling deraf | |
| DK0685235T3 (da) | Ekstrakter af Piliostigma thonningii, anvendelse heraf og formuleringer, som indeholder dem |